Cardiff, United Kingdom

Gwynn Pennant Ellis


Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 31(Granted Patents)


Location History:

  • Rhiwbina, WA (1976)
  • Cardiff, WA (1976 - 1977)
  • Rhiwbina, EN (1977)

Company Filing History:


Years Active: 1976-1977

Loading Chart...
6 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Gwynn Pennant Ellis**

Introduction

Gwynn Pennant Ellis, an accomplished inventor based in Cardiff, GB, has made significant strides in the field of chemical innovations. With a portfolio that includes six patents, Ellis has demonstrated a commitment to developing compounds with notable biological activity. His work has implications in various therapeutic contexts, particularly in inhibiting the release of spasmogenic substances.

Latest Patents

Ellis's latest patents include groundbreaking compounds such as quinaldic acid derivatives. These compounds are characterized by a general formula where R1, R2, and R3 can vary between hydrogen atoms, alkyl groups, nitro groups, halogen atoms, or more complex structures involving nitrogen and oxygen atoms. These derivatives hold promise due to their biological activity, particularly in controlling antigen-antibody reaction consequences.

Another noteworthy patent is the tetrazole-containing naphthyridine-3-carboxamides. Similar to his previous work, these compounds are defined by complex structures that include various substituents, allowing for potential pharmaceutical applications in treating a range of conditions. Both of these innovations underscore Ellis's dedication to chemical research and development.

Career Highlights

Working with Allen & Hanburys Limited, a prominent company in the pharmaceutical sector, Ellis has paved the way for advancements in drug development. His experience with such a well-regarded institution has provided him with the platform to bring his innovative ideas to fruition. Throughout his career, Ellis has consistently exhibited a deep understanding of complex chemical interactions that translates into practical applications.

Collaborations

In his professional journey, Gwynn Pennant Ellis has collaborated with esteemed colleagues such as David Edmund Bays and David Martin Waters. These collaborations have enriched the research environment, facilitating the exchange of ideas and enhancing the potential outcomes of their innovative projects.

Conclusion

The work of Gwynn Pennant Ellis exemplifies the spirit of innovation within the chemical field. With six impactful patents to his name, his contributions are expected to influence future research and development in pharmaceuticals. As he continues to explore the vast possibilities within his area of expertise, Ellis remains a pivotal figure in advancing chemical innovations that can lead to significant improvements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…